These findings were suggestive of T-cell lymphoma. Serologies for tuberculosis ... We diagnosed folliculotropic mycosis fungoides with early large-cell transformation (stage IIIB). We referred the ...

SGX301 has shown rapid and sustained benefit in early cutaneous T-cell lymphoma in an investigator-initiated study, with good ...

It's a subdued start to trading with tariff talk dampening US markets. Pharmaceutical and Energy stocks are the unlucky ...

The company is targeting Cutaneous T Cell Lymphoma and more specifically mycosis fungoides, a rare type of skin lymphoma. Finally, Norwest Minerals (ASX:NWM) has obtained a mining lease covering ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

The clinical study RW-HPN-MF-01, "Assessment of Treatment with Visible Light Activated Synthetic Hypericin Ointment in Mycosis Fungoides ... About Cutaneous T-Cell Lymphoma (CTCL) CTCL is a ...

Interim Results from FDA-Funded Study Reinforces HyBryte's Rapid Response and Strong Safety Profile PRINCETON, N.J., April 14, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix ...

It doesn’t make ... of mycosis fungoides or Sézary syndrome; — Oxlumo, for the treatment of hyperoxaluria type 1; — Epkinly, for relapsed or refractory diffuse large B-cell lymphoma ...